22nd Century Group Inc. Common Stock (XXII)
Stock · NASDAQ · Health Care
$0.3371as of 10/16/2026
Price chart
Active signals
XXII Signal Track Record
How signals performed across all stocks →What XXII's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 29 | -32.6% | 21% | September 28, 2026 |
| Bollinger Band Breakout | 9 | -23.0% | 11% | September 25, 2025 |
| Any 20-session window (baseline) | -26.7% | 13% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About XXII
22nd Century Group, Inc., a tobacco products company, manufactures, distributes, and sells proprietary new reduced nicotine tobacco products in the United States. The company offers reduced nicotine content tobacco and very low nicotine combustible cigarette products. It also provides contract manufacturing services for conventional combustible tobacco products for third-party brands, as well as turnkey contract manu…
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- Employees
- 32
- Website
- www.xxiicentury.com/
Fundamentals
- 1-day range
- $0.5618$0.65
- Market cap
- $2.23M
- P/E (trailing)
- —
- P/E (forward)
- -0.04
- EPS (trailing)
- $221.66
- Dividend yield
- —
- Beta
- 0.70
- Avg. volume
- 102.2K
How 22nd Century Group Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 26, 2026 · via SEC EDGAR / Finnhub
22nd Century Group Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- XXII22nd Century Group Inc. Common Stock$0.335▼ 46.57%Market cap $2.23MP/E —$0.63411$540
- AKANAkanda Corp. Common Shares$1.2▼ 8.40%Market cap $2.90MP/E —$1.27$78.9
- IMCCIM Cannabis Corp. Common Shares$1.39▲ 4.51%Market cap $768.0KP/E —$0.475$3.16
- BONBon Natural Life Limited Class A Ordinary Shares$1.14▲ 0.53%Market cap $8.86MP/E —$0.95$2.34
- MTEXMannatech Incorporated Common Stock$7.13▲ 0.00%Market cap $9.84MP/E —$3.8$12.45
- NAIINatural Alternatives International Inc. Common Stock$1.15▲ 2.68%Market cap $14.94MP/E —$1.08$4.96
- BTMDBiote Corp. Class A Common Stock$1.09▼ 2.25%Market cap $61.26MP/E 6.81$1$3.26
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| XXII 22nd Century Group Inc. Common Stock | $2.23M | — | $0.335 | ▼ 46.57% | $0.63411$540 |
| AKAN Akanda Corp. Common Shares | $2.90M | — | $1.2 | ▼ 8.40% | $1.27$78.9 |
| IMCC IM Cannabis Corp. Common Shares | $768.0K | — | $1.39 | ▲ 4.51% | $0.475$3.16 |
| BON Bon Natural Life Limited Class A Ordinary Shares | $8.86M | — | $1.14 | ▲ 0.53% | $0.95$2.34 |
| MTEX Mannatech Incorporated Common Stock | $9.84M | — | $7.13 | ▲ 0.00% | $3.8$12.45 |
| NAII Natural Alternatives International Inc. Common Stock | $14.94M | — | $1.15 | ▲ 2.68% | $1.08$4.96 |
| BTMD Biote Corp. Class A Common Stock | $61.26M | 6.81 | $1.09 | ▼ 2.25% | $1$3.26 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 22nd Century Group (XXII) Stock Surges Over 64% After Hours on Sales Growthbenzinga · 10/16/2026
- The trading volume of these stocks is deviating from the norm in today's session.ChartMill · 9/28/2026
- 22nd Century Group's Reduced-Nicotine Tobacco Platform Positioned to Support France's Nicotine-Reduction InitiativeYahoo · 9/28/2026
- 22nd Century Group Announces Study From France's ANSES Identifies Its Technology Supportive In Nicotine Reduction In Combustible Tobacco ProductsBenzinga · 9/28/2026
- 22nd Century Group Urges Policymakers and FDA to Enact and Implement the Reduced Nicotine Content Standard, Citing Years Without a Final RuleYahoo · 9/24/2026
- 22nd Century Group Calls On HHS And FDA Secretary Kennedy, Acting FDA Commissioner Diamantas And CTP Director Koplow To Enact And Implement The Reduced Nicotine Content StandardBenzinga · 9/24/2026
- Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving PremarketBenzinga · 9/24/2026
- 'U.S. Regulators Plan Major Move To Speed Authorizations Of Vapes, Tobacco Pouches; Move Comes Despite Lawmakers Voicing Concern About Recent Flavor Approvals' - WSJ ExclusiveBenzinga · 9/23/2026
- Full Transcript: 22nd Century Group Q2 2026 Earnings CallBenzinga · 9/21/2026
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
XXII's Reduced-Nicotine Platform Gains Attention in France
XXII has announced that its reduced‑nicotine tobacco platform aligns with France’s nicotine‑reduction policy. A study from France’s ANSES confirms the technology supports lower‑nicotine combustible products. Trading volume is higher than usual, suggesting growing interest. The stock sits near a low RSI, indicating it may be oversold.
XXII's Reduced-Nicotine Platform Gains Attention in France. XXII has announced that its reduced‑nicotine tobacco platform aligns with France’s nicotine‑reduction policy. A study from France’s ANSES confirms the technology supports lower‑nicotine combustible products. Trading volume is higher than usual, suggesting growing interest. The stock sits near a low RSI, indicating it may be oversold.